Streetbeat News

Revenues

WING

Wingstop's Q3 2024 earnings per share missed estimates, but sales exceeded expectations, showing significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:06 pm

SITC

SITE Centers projects its 2024 property level Net Operating Income (NOI) to range between $94.7 million and $96.9 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:06 pm

EXEL

Exelixis shares rose following the announcement of strong Q3 financial results and an increase in FY24 sales guidance, surpassing expectations.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:03 pm

AVT

Avnet (NASDAQ:AVT) reported Q1 2025 earnings per share of $0.92, surpassing the analyst estimate of $0.86. The company's sales were $5.604 billion, exceeding the expected $5.431 billion, but down from $6.336 billion the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:03 pm

ITW

Illinois Tool Works reported Q3 2024 earnings per share of $2.65, surpassing the analyst estimate of $2.53. However, their sales of $3.966 billion fell short of the expected $4.017 billion, marking a 1.61% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:02 pm

GTES

Gates Industrial Corp reported Q3 earnings of $0.33 per share, beating estimates of $0.31, but sales of $830.70M missed the $831.18M estimate. Earnings decreased by 5.71% and sales by 4.83% compared to last year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 12:01 pm

LLY

Eli Lilly's Q3 earnings report showed a significant revenue increase driven by Mounjaro sales, but missed expectations, leading to a stock drop. The company also lowered its 2024 guidance.

Portfolio Pulse from Vandana Singh

October 30, 2024 | 11:51 am

ASPI

LLY

RDDT

Reddit shares surged 24% after reporting strong Q3 results and positive Q4 guidance. Eli Lilly shares fell 11% due to disappointing Q3 earnings and sales. ASP Isotopes shares jumped 48% following a term sheet agreement with TerraPower for funding a HALEU production facility.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:51 am

ITCI

Intra-Cellular Therapies (ITCI) has raised its 2024 net product sales guidance for CAPLYTA to $665M-$685M, up from the previous $650M-$680M. The company also narrowed its SG&A and R&D expense guidance ranges for the year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:43 am

ABBV

AbbVie reported Q3 2024 earnings per share of $3.00, surpassing the analyst estimate of $2.92. The company's sales reached $14.46 billion, exceeding the expected $14.28 billion and marking a 3.83% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:39 am